Top Markets
Coin of the day
ImageneBio Inc ImageneBio Inc

ImageneBio Inc

IMA
Rank in Stocks #24235
ImageneBio Inc (IMA) is a biotechnology company with therapies currently... ImageneBio Inc (IMA) is a biotechnology company with therapies currently undergoing human trials. The firm concentrates on creating innovative medical treatments for a variety of immune-related and inflammatory diseases. A key component of their pipeline is IMG-007, a non-depleting anti-OX40 monoclonal antibody, which is now in Phase 2b clinical studies targeting atopic dermatitis.
Share Price
$5.61
Last synced: 2026-08-21
Market Cap
$63.22M
Change (1 day)
-0.09%
Change (1 year)
-60.61%
Country
US
Trade ImageneBio Inc (IMA)

Category

Earnings for ImageneBio Inc (IMA)
Earnings in 2026 TTM: 0
According to ImageneBio Inc latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for ImageneBio Inc from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$5.27B -
US
$1.95B -
NL
$-3.09B -
US
$1.61B -
AU
- -
CH